Latest news for Montauk Metals (OTC:GAYGF) Stock

Montauk Metals Inc Formerly Galway Gold Inc is an exploration-stage company. It is engaged in the acquisition, exploration, and development of mineral resource properties. The company's mineral property is the Vetas Project.

News

Intraday Update

Markets

Movers

Trading Ideas

AGEEF

ALXEF

ARLP

ARTL

BRGGF

CCRGF

CDGXF

CEIX

CWBHF

DDMX

DRRSF

ECOR

ELGX

EMERALD HEALTH THERAPUTCS by Emerald Health Therapeutics Inc.

EMHTF

FEWP

FLWPF

FNGR

GAXY

GAYGF

GCAN

GFTX

GGBXF

GLBS

GNMK

GPOR

GSUM

HAPP

HESG

HRVOF

IDGBF

INDXF

INND

IPDQF

KAYS

KRKR

MFCSF

MJNE

MMNFF

MODERN CINEMA GROUP INC by Modern Cinema Group, Inc.

MOCI

MRAM

MTTWF

NAKD

NOSUF

OWPC

OWRDF

PACB

PDSB

PFGTF

PHIO

PROS

RDDTF

REPO

RNLSY

ROSE

RYDBF

RYPPF

SEEK

SEXHF

SINT

SNDL

SNNVF

SPRWF

SPSTF

STGPF

STWC

TGIFF

TNXP

TSRYY

TUWOY

VBIX

VLRX

XERS

YAYO

VRSRF

SPOI

AZIL

Stocks That Hit 52-Week Lows On Tuesday

Movers & Shakers

General

AGHC

ANGI

ASCOT RESOURCES LTD by Ascot Resources Ltd.

AOTVF

ASDZF

ARTEMIS THERAPEUTICS INC by Artemis Therapeutics, Inc.

ATMS

BIG BLOCKCHAIN INTELGNCE by Big Blockchain Intelligence Group Inc.

BBKCF

BFALL

BSPK

BYZN

CCSB

CELLCUBE ENERGY STORAGE by Cellcube Energy Storage Sys Inc.

CECBF

CEFC

CHDGF

China TechFaith Wirelessmmunication Technology

CNTF

COFOL

CTIB

CYIG

DFMTF

DMNKF

DPLS

EOPT

ESTR

FLES

FRLI

FTPLF

FTXP

FUAPF

FUTL

GBHPF

HQGE

HSKA

HTGM

INQD

INSYQ

IPNFF

IRIX

ISWH

IVITF

JINFF

MCIG

MRSN

MXROF

MYOV

NABIF

NOHO

NRBT

OPMZ

OXBDF

OZSC

PDLI

PDNLA

PHVAF

PTVL

QMC QUANTUM MINERALS CORP by QMC Quantum Minerals Corp.

QMCQF

REGEN BIOPHARMA INC PFD by Regen Biopharma, Inc.

RGBPP

RTNB

RTTR

SAMMF

SHGXY

SNAVF

SPLIF

STKXF

SYHBF

SZBI

TBEV

TRIB

TTNP

TUSK

TWOH

VIDA

VRME

VVCIF

VYEY

WMLLF

FRFFF

UNJCF

GRDZF

DGTLF

BRTZF

SDXEF

SDPI

POROF

BFARF

SCYYF

NVLPF

GEEPF

MMIRF

GTARF

Stocks That Hit 52-Week Lows On Friday

MONTAUK METALS INC by Montauk Metals Inc.

Montauk Metals Inc

The analysis demonstrated that after a median follow-up of more than five years, patients treated with Yescarta continued to experience durable response and long-term survival. The data were shared in an oral presentation (Abstract #864) during the 66th American Society of Hematology (ASH) Annual Meeting and Exposition.
"There is growing evidence that people with follicular lymphoma and marginal zone lymphoma can experience long-term survival after one Yescarta treatment," said Dominique Tonelli, VP, Global Head of Medical Affairs, Kite. "With no lymphoma-specific events in the five-year follow-up of ZUMA-5 patients, Yescarta may offer patients the chance to live longer without need for subsequent therapy and a potential cure."

GILD

Gilead Company Kite Reports Results From Five-year Follow-up Analysis Of ZUMA-5, A Phase 2 Study Of Yescarta

Multiple analyses underscore durable efficacy and well-established safety profile of Breyanzi (lisocabtagene maraleucel; liso-cel) in leukemia and several types of lymphoma.
 &nbsp;

Bristol Myers Squibb Reports Results From 18 Presentations; Data Demonstrate Efficacy, Durability And Safety Of Currently Available Therapies In Blood Cancers

Nio Inc &#8211; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) shares gained 12.36% to $5.18 on Monday. Shares of U.S.-listed Chinese stock traded higher following reports suggesting Chinese officials would embrace a &#8220;moderately loose&#8221; monetary policy ahead of China's Central Economic Work Conference. 
What To Know: This key policy meeting, expected to outline economic strategies for 2025, has fueled optimism among investors, particularly after the Politburo, led by President Xi Jinping, pledged <a href="https://www.benzinga.com/government/regulations/24/12/42391254/us-listed-chinese-stocks-jump-on-chinas-stimulus-measures-looser-monetary-policy-assurances">"more proactive"</a> fiscal measures and "moderately" looser monetary policies to stimulate domestic consumption and stabilize key markets.
Nio is well-positioned to benefit from these measures, as the EV industry is a cornerstone of China's push for sustainable economic growth. Government support for clean energy and advanced technology sectors is expected to create tailwinds for Nio's operations.
Read Also: <a href="https://www.benzinga.com/news/earnings/24/12/42400723/oracle-q2-earnings-revenue-miss-eps-miss-ai-growth-ellison-says-opportunity-is-unimaginable">Oracle Q2 Earnings: Revenue Miss, EPS Miss, AI Growth, Ellison Says &#8216;Opportunity Is Unimaginable&#8217;</a>
Policies promoting infrastructure development and increased consumer spending could further drive demand for premium electric vehicles, a segment where NIO has built a strong brand presence.
Additionally, potential interest rate cuts and fiscal expansion could reduce borrowing costs for Nio, enabling the company to invest in innovation and scale production. This is especially critical as Nio continues to expand its product lineup and charging infrastructure.&nbsp;
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, Nio has a 52-week high of $9.57 and a 52-week low of $3.61. 
Also Read:
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42360675/nvidia-could-become-taiwan-semis-third-us-plant-customer-but-with-a-catch" target="_blank" rel="noreferrer noopener">Nvidia Could Become Taiwan Semi's Third US Plant Customer, But With A Catch</a></li>
</ul>
Photo: Sundry Photography on Shutterstock

Global

What's Going On With NIO Stock Today?

The study's primary endpoint of progression-free survival (PFS) was met at primary analysis, demonstrating pirtobrutinib was superior to investigator's choice of idelalisib plus rituximab (IdelaR) or bendamustine plus rituximab (BR), based on independent review committee (IRC) assessment.
Today's updated results&nbsp;corresponding to the final prespecified analysis, demonstrate consistent improvement in PFS for patients treated with pirtobrutinib, with a reduction in risk of relapse, disease or death by&nbsp;46% compared to IdelaR or BR.&nbsp;
Pirtobrutinib also demonstrated clinically meaningful improvements in other secondary endpoints such as investigator-assessed PFS (median PFS: 15.3 vs. 9.2 months.

Eli Lilly Reports Results From Phase 3 BRUIN CLL-321 Trial Evaluating Pirtobrutinib; Study's Primary Endpoint Of Progression-Free Survival Was Met At Primary Analysis

TSC-100 and TSC-101 are designed to treat residual disease and prevent relapse in patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplastic syndrome (MDS) undergoing allogeneic hematopoietic cell transplantation (HCT) with reduced intensity conditioning.
The company said it is highly encouraged by the preliminary ALLOHA study results, which suggest that TSC-100 and TSC-101 have the potential to eliminate residual disease and prevent relapse in patients with AML, ALL, or MDS post-HCT.

TCRX

TScan Therapeutics To Present Updated Results From Ongoing ALLOHA Phase 1 Trial Of TSC-100 And TSC-101 At ASH Meeting

The Multidisciplinary Association for Psychedelic Studies (MAPS) introduced "Music is the Bridge," a new campaign that combines artist-curated playlists with free <a href="https://www.benzinga.com/markets/psychedelics">psychedelic education. </a>
Starting Monday, the project aims to make psychedelic experiences safer, more accessible and more meaningful.
<h3 class="wp-block-heading">Playlists From Artists And Organizations</h3>
The campaign includes playlists from artists and organizations like Lil Yachty, Melissa Etheridge, Brandon Boyd, Reggie Watts, CloZee, Boreta, Superposition, Good Trip Studios, East Forest, Dr. Bronner's as well as MAPS founder and president Rick Doblin aka "DJ Doblin."
See Also: <a href="https://www.benzinga.com/24/12/42394033/first-study-to-explore-psychedelics-and-sexual-health-shows-promising-results">Sexual Health: Psychedelics Found To Enhance Function In Imperial College Study</a>
Each playlist enhances different aspects of the psychedelic experience, from the journey itself to moments of reflection and integration.
"Music is medicine. This is something that cultures around the world have long known,&#8221; said Etheridge in a press release. &#8220;And in combination with plant medicines or psychedelics, they amplify one another, opening up a powerful journey to feel deeply and find truths."
GRAMMY-nominated Lil Yachty added, "Whenever I take a trip, I often spend the end of it reflecting and integrating my experiences—trying to understand why certain things are happening, what I'm doing well, and whether there's anything I could be doing differently."
<h3 class="wp-block-heading">Lead Singer Of Incubus</h3>
"Music and psychedelics have a partnership, a commingling that stretches back into prehistory," said Brandon Boyd of Incubus. "We could almost suggest that one wouldn't exist without the other in certain creative circles. I know with great certainty that psychedelics, predominantly psilocybin, have been deeply impactful to me in my experience as a younger man but also as I continue my creative pursuits as an adult. They are like a gift from God put here to offer access to other worlds, and a happy byproduct of that "access" is the music we hear along the way." Boreta, formerly of Glitch Mob, added: &#8220;My relationship with music and life is shaped by psychedelics, which have revealed the transformative power of sound and helped me connect with something larger than us all.&#8221;
<a href="https://www.benzinga.com/markets/cannabis/24/09/40823224/multidisciplinary-association-for-psychedelic-studies-eyes-state-level-legalization-after-fda-de">MAPS</a> plans to release new playlists each month as part of the campaign.
<h3 class="wp-block-heading">Free Psychedelic Education</h3>
In addition to the playlists, MAPS is offering a free course &#8220;Psychedelic Fundamentals,&#8221; which covers the basics of history, science, therapeutic uses and safety.
Normally priced at $29, the course takes only a few hours to complete. It provides key information for safe exploration, with a broad overview of the most interesting and important aspects of psychedelic history, science, clinical research, therapeutic uses and harm reduction.
Participants also get the MAPS Integration Station workbook, which helps them process and learn from their psychedelic experiences.
<h3 class="wp-block-heading">Join The Conversation</h3>
MAPS encourages people to share their favorite playlists on social media using the hashtag #MusicIsTheBridge. The campaign also features exclusive merchandise, including a commemorative T-shirt, available through the MAPS store.
For more details, playlists and educational resources, visit MAPS&#8217; website.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42346427/mapping-how-ayahuasca-affects-fear-circuits-key-insights-from-new-research">Mapping How Ayahuasca Affects Fear Circuits: Key Insights From New Research</a></li>
</ul>
Cover image made with AI.

Cannabis

Maps Drops Free Psychedelic Education And Artist-Curated Playlists - Start Your Journey Here

Comments

Montauk Metals

News

Latest news for Montauk Metals (OTC:GAYGF) Stock

Tuesday, February 11, 2020

Friday, September 13, 2019

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga